REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA

Clinical trials for REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA trials appear

Sign up with your email to follow new studies for REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Targeted radiation attack on tough brain tumors in kids

Disease control Recruiting now

This study is testing a drug called Lutathera in children and young adults (ages 4 to 39) with aggressive brain or spinal cord tumors that have come back or gotten worse after standard treatments. Lutathera is a targeted radiation therapy that seeks out and attaches to specific m…

Matched conditions: REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA

Get alerted when new REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA trials appear

Targeted radiation attack on tough brain tumors in kids